Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors

This publication has 12 references indexed in Scilit:

• The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
  Seminars in Oncology, 2003
• Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride
  Applied Radiation and Isotopes, 2003
• Labeled EGFr‐TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug
  International Journal of Cancer, 2002
• 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity
  Journal of Medicinal Chemistry, 2001
• Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase
  Nuclear Medicine and Biology, 2001
• Epidermal growth factor-related peptides and their receptors in human malignancies
  Published by Elsevier ,2000
• Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy
  Drugs, 2000
• Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor
  Journal of Medicinal Chemistry, 1999
• Recommendations for a practical production of [11C]methyl iodide
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987
• 88. The chemistry of simple heterocyclic systems. Part I. Reactions of 6- and 7-nitro-4-hydroxyquinazoline and their derivatives
  Journal of the Chemical Society, 1948